Current knowledge and systematic review of viruses associated with Crohn's disease

Reviews in Medical Virology

Volumn 23, Issue 3, 2013, Pages 145-171

  Wagner, Josef ^a,b   Sim, Winnie H ^a   Lee, Katherine J ^a,b   Kirkwood, Carl D ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; CROHN DISEASE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; MEASLES VIRUS; MUMPS VIRUS; NOROVIRUS; RETROVIRUS; REVIEW; ROTAVIRUS; RUBELLA VIRUS; SYSTEMATIC REVIEW; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS INFECTION;

CROHN DISEASE; HUMANS; VIRUS DISEASES;

EID: 84877588907     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1720     Document Type: Review

References (130)

1. Crohn BB. The Pathology of Acute Regional Ileitis. American Journal of Digestive Diseases 1965; 10: 565-72.
2. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis; a pathologic and clinical entity. American Journal of Medicine 1952; 13(5): 583-90.
3. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. 1932. The Mount Sinai Journal of Medicine 2000; 67(3): 263-8.
4. Abubakar I, Myhill D, Aliyu SH, Hunter PR. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: A systematic review and meta-analysis. Inflammatory Bowel Diseases 2008; 14(3): 401-10.
5. Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. The Lancet Infectious Diseases 2007; 7(9): 607-13.
6. Wagner J, Sim W, Bishop RF, Catto-Smith AG, Cameron DJ, Kirkwood CD. Mycobacterium avium subspecies paratuberculosis in children with early-onset crohn's disease: A longitudinal follow-up study. Inflammatory Bowel Diseases.
7. Agus SG, Dolin R, Wyatt RG, Tousimis AJ, Northrup RS. Acute infectious nonbacterial gastroenteritis: intestinal histopathology. Histologic and enzymatic alterations during illness produced by the Norwalk agent in man. Annals of Internal Medicine 1973; 79(1): 18-25.
8. Bishop RF, Davidson GP, Holmes IH, Ruck BJ. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 1973; 2(7841): 1281-3.
9. Cave DR, Mitchell DN, Kane SP, Brooke BN. Further animal evidence of a transmissible agent in Crohn's disease. Lancet 1973; 2(7838): 1120-2.
10. Mitchell DN, Rees RJ. Agent transmissible from Crohn's disease tissue. Lancet 1970; 2(7665): 168-71.
11. Beeken WL, Mitchell DN, Cave DR. Evidence for a transmissible agent in Crohn's disease. Clinics in Gastroenterology 1976; 5(2): 289-302.
12. Gitnick GL, Arthur MH, Shibata I. Cultivation of viral agents from Crohn's disease. A new sensitive system. Lancet 1976; 2(7979): 215-7.
13. Gitnick GL, Rosen VJ. Electron microscopic studies of viral agents in Crohn's disease. Lancet 1976; 2(7979): 217-9.
14. Riemann JF. Further electron microscopic evidence of virus-like particles in Crohn's disease. Acta Hepatogastroenterol (Stuttg) 1977; 24(2): 116-8.
15. Phillpotts RJ, Hermon-Taylor J, Teich NM, Brooke BN. A search for persistent virus infection in Crohn's disease. Gut 1980; 21(3): 202-7.
16. Dvorak AM, Dickersin GR, Osage JE, Monahan RA. Absence of virus structures in Crohn's disease tissues studied by electron microscopy. Lancet 1978; 1(8059): 328.
17. McLaren LC, Gitnick G. Ulcerative colitis and Crohn's disease tissue cytotoxins. Gastroenterology 1982; 82(6): 1381-8.
18. Phillpotts RJ, Hermon-Taylor J, Brooke BN. Virus isolation studies in Crohn's disease: a negative report. Gut 1979; 20(12): 1057-62.
19. Yoshimura HH, Estes MK, Graham DY. Search for evidence of a viral aetiology for inflammatory bowel disease. Gut 1984; 25(4): 347-55.
20. DeHoratius RJ, Strickland RG, Miller WC, et al. Antibodies to synthetic polyribonucleotides in spouses of patients with inflammatory bowel disease. Lancet 1978; 1(8074): 1116-9.
21. Bergstrand LO, Gustafsson BE, Holmstrom B, Norin KE. Ileal Crohn tissue and concomitant flora inoculated into germfree rats. Acta Chirurgica Scandinavica 1981; 147(8): 697-701.
22. Bergstrand O, Holmstrom B, Gustafsson BE. Contamination of germfree animals with intestinal Crohn tissue. A preliminary report. Acta Chirurgica Scandinavica. Supplementum 1978; 482: 48-50.
23. Heatley RV, Bolton PM, Owen E, Williams WJ, Hughes LE. A search for a transmissible agent in Crohn's disease. Gut 1975; 16(7): 528-32.
24. Wallace BC, Schmid CH, Lau J, Trikalinos TA. Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Medical Research Methodology 2009; 9: 80.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7(3): 177-88.
26. Higgins JP. Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. International Journal of Epidemiology 2008; 37(5): 1158-60.
27. Epstein MA, Achong BG, Barr YM. Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet 1964; 1(7335): 702-3.
28. Spaete RR, Gehrz RC, Landini MP. Human cytomegalovirus structural proteins. Journal of General Virology 1994; 75(Pt 12): 3287-308.
29. Grtsky H, Glade PR, Hirshaut Y, Sachar D, Janowitz HD. Herpes-like virus and granulomatous colitis. Lancet 1970; 2(7685): 1256-7.
30. Kane SP, Nye FJ. E.B.-virus antibody in Crohn's disease. Lancet 1971; 1(7692): 233.
31. Wakefield AJ, Fox JD, Sawyerr AM, et al. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. Journal of Medical Virology 1992; 38(3): 183-90.
32. Reijasse D, Le Pendeven C, Cosnes J, et al. Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy. Inflammatory Bowel Diseases 2004; 10(2): 85-90.
33. Bertalot G, Villanacci V, Gramegna M, et al. Evidence of Epstein-Barr virus infection in ulcerative colitis. Digestive and Liver Disease 2001; 33(7): 551-8.
34. Yanai H, Shimizu N, Nagasaki S, Mitani N, Okita K. Epstein-Barr virus infection of the colon with inflammatory bowel disease. American Journal of Gastroenterology 1999; 94(6): 1582-6.
35. Spieker T, Herbst H. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. American Journal of Pathology 2000; 157(1): 51-7.
36. Gehlert T, Devergne O, Niedobitek G. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease. Journal of Medical Virology 2004; 73(3): 432-8.
37. Marszalek A, Marciniak R, Szkaradkiewicz A, et al. Inflammatory bowel disease - is there something new in the immunological background? Folia Histochemica et Cytobiologica 2011; 49(2): 357-62.
38. Ruther U, Nunnensiek C, Muller HA, Bader H, May U, Jipp P. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease). Hepato-Gastroenterology 1998; 45(21): 691-9.
39. Wong NA, Herbst H, Herrmann K, et al. Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas. The Journal of Pathology 2003; 201(2): 312-8.
40. Goodgame RW. Gastrointestinal cytomegalovirus disease. Annals of Internal Medicine 1993; 119(9): 924-35.
41. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Reviews in Medical Virology 2010; 20(4): 202-13.
42. Farmer GW, Vincent MM, Fuccillo DA, et al. Viral investigations in ulcerative colitis and regional enteritis. Gastroenterology 1973; 65(1): 8-18.
43. Swarbrick ET, Kingham JG, Price HL, et al. Chlamydia, cytomegalovirus, and Yersinia in inflammatory bowel disease. Lancet 1979; 2(8132): 11-2.
44. Roche JK, Huang ES. Viral DNA in inflammatory bowel disease. CMV-bearing cells as a target for immune-mediated enterocytolysis. Gastroenterology 1977; 72(2): 228-33.
45. Cottone M, Pietrosi G, Martorana G, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. American Journal of Gastroenterology 2001; 96(3): 773-5.
46. de Saussure P, Lavergne-Slove A, Mazeron MC, Alain S, Matuchansky C, Bouhnik Y. A prospective assessment of cytomegalovirus infection in active inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 2004; 20(11-12): 1323-7.
47. Fisher NC, Yee L, Nightingale P, McEwan R, Gibson JA. Measles virus serology in Crohn's disease. Gut 1997; 41(1): 66-9.
48. Kim JJ, Simpson N, Klipfel N, Debose R, Barr N, Laine L. Cytomegalovirus infection in patients with active inflammatory bowel disease. Digestive Diseases and Sciences 55(4): 1059-65.
49. Kishore J, Ghoshal U, Ghoshal UC, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. Journal of Medical Microbiology 2004; 53(Pt 11): 1155-60.
50. Kuwabara A, Okamoto H, Suda T, Ajioka Y, Hatakeyama K. Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. Journal of Gastroenterology 2007; 42(10): 823-9.
51. Lidar M, Langevitz P, Barzilai O, et al. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Annals of the New York Academy of Sciences 2009; 1173: 640-8.
52. Maher MM, Nassar MI. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Digestive Diseases and Sciences 2009; 54(11): 2456-62.
53. Rahbar A, Bostrom L, Lagerstedt U, Magnusson I, Soderberg-Naucler C, Sundqvist VA. Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflammatory Bowel Diseases 2003; 9(3): 154-61.
54. Takahashi Y, Tange T. Prevalence of cytomegalovirus infection in inflammatory bowel disease patients. Diseases of the Colon and Rectum 2004; 47(5): 722-6.
55. Vega R, Bertran X, Menacho M, et al. Cytomegalovirus infection in patients with inflammatory bowel disease. American Journal of Gastroenterology 1999; 94(4): 1053-6.
56. Criscuoli V, Casa A, Orlando A, et al. Severe acute colitis associated with CMV: a prevalence study. Digestive and Liver Disease 2004; 36(12): 818-20.
57. Dimitroulia E, Spanakis N, Konstantinidou AE, Legakis NJ, Tsakris A. Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2006; 12(9): 879-84.
58. Knosel T, Schewe C, Petersen N, Dietel M, Petersen I. Prevalence of infectious pathogens in Crohn's disease. Pathology Research and Practice 2009; 205(4): 223-30.
59. D'Ovidio V, Vernia P, Gentile G, et al. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. Journal of Clinical Virology 2008; 43(2): 180-3.
60. Domenech E, Vega R, Ojanguren I, et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflammatory Bowel Diseases 2008; 14(10): 1373-9.
61. Osaki R, Andoh A, Tsujikawa T, et al. Acute cytomegalovirus infection superimposed on corticosteroid-naive ulcerative colitis. Internal Medicine 2008; 47(14): 1341-4.
62. Drouin E, Seidman E, Russo P, Deslandres C. Gastrointestinal cytomegalovirus infection complicating Crohn's disease in an adolescent without AIDS. Journal of Pediatric Gastroenterology and Nutrition 1997; 25(2): 210-3.
63. Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflammatory Bowel Diseases 2010; 16(9): 1620-7.
64. Sura R, Gavrilov B, Flamand L, et al. Human herpesvirus-6 in patients with Crohn's disease. APMIS 118(5): 394-400.
65. Van Kruiningen HJ, Joossens M, Vermeire S, et al. Familial Crohn's disease in Belgium: pedigrees, temporal relationships among cases, and family histories. Journal of Clinical Gastroenterology 2007; 41(6): 583-90.
66. Daikoku EM, Kohno C, Sano Kouichi T. Analysis of Morphology and Infectivity of Measles Virus Particles. Bulletin of the Osaka Medical College 2007; 53(2): 107-14.
67. Enders JF, Peebles TC. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proceedings of the Society for Experimental Biology and Medicine 1954; 86(2): 277-86.
68. Hilleman MR. Past, present, and future of measles, mumps, and rubella virus vaccines. Pediatrics 1992; 90(1 Pt 2): 149-53.
69. Chiba M, McLaren LC, Strickland RG. Immunity to cytopathic agents associated with Crohn's disease: a negative study. Gut 1982; 23(4): 333-9.
70. Wakefield AJ, Pittilo RM, Sim R, et al. Evidence of persistent measles virus infection in Crohn's disease. Journal of Medical Virology 1993; 39(4): 345-53.
71. Ekbom A, Wakefield AJ, Zack M, Adami HO. Perinatal measles infection and subsequent Crohn's disease. Lancet 1994; 344(8921): 508-10.
72. Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995; 345(8957): 1071-4.
73. Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn's disease after in-utero measles virus exposure. Lancet 1996; 348(9026): 515-7.
74. Davis RL, Kramarz P, Bohlke K, et al. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Archives of Pediatrics & Adolescent Medicine 2001; 155(3): 354-9.
75. Feeney M, Ciegg A, Winwood P, Snook J. A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group. Lancet 1997; 350(9080): 764-6.
76. Ghosh S, Armitage E, Wilson D, Minor PD, Afzal MA. Detection of persistent measles virus infection in Crohn's disease: current status of experimental work. Gut 2001; 48(6): 748-52.
77. Robertson DJ, Sandler RS. Measles virus and Crohn's disease: a critical appraisal of the current literature. Inflammatory Bowel Diseases 2001; 7(1): 51-7.
78. Seagroatt V, Goldacre MJ. Crohn's disease, ulcerative colitis, and measles vaccine in an English population, 1979-1998. Journal of Epidemiology and Community Health 2003; 57(11): 883-7.
79. Haslam N, Mayberry JF, Hawthorne AB, Newcombe RG, Holmes GK, Probert CS. Measles, month of birth, and Crohn's disease. Gut 2000; 47(6): 801-3.
80. Morris DL, Montgomery SM, Thompson NP, Ebrahim S, Pounder RE, Wakefield AJ. Measles vaccination and inflammatory bowel disease: a national British Cohort Study. American Journal of Gastroenterology 2000; 95(12): 3507-12.
81. Afzal MA, Armitage E, Ghosh S, Williams LC, Minor PD. Further evidence of the absence of measles virus genome sequence in full thickness intestinal specimens from patients with Crohn's disease. Journal of Medical Virology 2000; 62(3): 377-82.
82. Haga Y, Funakoshi O, Kuroe K, et al. Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction. Gut 1996; 38(2): 211-5.
83. Iizuka M, Nakagomi O, Chiba M, Ueda S, Masamune O. Absence of measles virus in Crohn's disease. Lancet 1995; 345(8943): 199.
84. Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hoshika A, Wakefield A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Digestive Diseases and Sciences 2000; 45(4): 723-9.
85. Folwaczny C, Loeschke K, Schnettler D, et al. Endothelial cell autoantibodies are a marker of disease susceptibility in inflammatory bowel disease but apparently not linked to persistent measles virus infection. Clinical Immunology 2000; 95(3): 197-202.
86. Daszak P, Purcell M, Lewin J, Dhillon AP, Pounder RE, Wakefield AJ. Detection and comparative analysis of persistent measles virus infection in Crohn's disease by immunogold electron microscopy. Journal of Clinical Pathology 1997; 50(4): 299-304.
87. Lewin J, Dhillon AP, Sim R, Mazure G, Pounder RE, Wakefield AJ. Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. Gut 1995; 36(4): 564-9.
88. Miyamoto H, Tanaka T, Kitamoto N, Fukuda Y, Shimoyama T. Detection of immunoreactive antigen, with a monoclonal antibody to measles virus, in tissue from a patient with Crohn's disease. Journal of Gastroenterology 1995; 30(1): 28-33.
89. Wakefield AJ, Ekbom A, Dhillon AP, Pittilo RM, Pounder RE. Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995; 108(3): 911-6.
90. Wakefield AJ, Sim R, Akbar AN, Pounder RE, Dhillon AP. In situ immune responses in Crohn's disease: a comparison with acute and persistent measles virus infection. Journal of Medical Virology 1997; 51(2): 90-100.
91. Chadwick N, Bruce IJ, Schepelmann S, Pounder RE, Wakefield AJ. Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction. Journal of Medical Virology 1998; 55(4): 305-11.
92. Bernstein CN, Rawsthorne P, Blanchard JF. Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease. Inflammatory Bowel Diseases 2007.
93. Balzola FA, Khan K, Pera A, Bonino F, Pounder RE, Wakefield AJ. Measles IgM immunoreactivity in patients with inflammatory bowel disease. Italian Journal of Gastroenterology and Hepatology 1998; 30(4): 378-82.
94. Balzola FA, Castellino F, Colombatto P, et al. IgM antibody against measles virus in patients with inflammatory bowel disease: a marker of virus-related disease? European Journal of Gastroenterology and Hepatology 1997; 9(7): 661-3.
95. Iizuka M, Saito H, Yukawa M, et al. No evidence of persistent mumps virus infection in inflammatory bowel disease. Gut 2001; 48(5): 637-41.
96. Kangro HO, Chong SK, Hardiman A, Heath RB, Walker-Smith JA. A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease. Gastroenterology 1990; 98(3): 549-53.
97. Bishop RF, Kirkwood C. Enteric Viruses. In Encyclopedia of Virology, 3rd edn, Mahy B, Regenmortel M (eds). Elsevier: 2008; 116-23.
98. Whorwell PJ, Phillips CA, Beeken WL, Little PK, Roessner KD. Isolation of reovirus-like agents from patients with Crohn's disease. Lancet 1977; 1(8023): 1169-71.
99. De Groote G, Desmyter J, Vantrappen G, Phillips CA. Rotavirus antibodies in Crohn's disease and ulcerative colitis. Lancet 1977; 1(8024): 1263-4.
100. Cartun RW, Van Kruiningen HJ, Pedersen CA, Berman MM. An immunocytochemical search for infectious agents in Crohn's disease. Modern Pathology 1993; 6(2): 212-9.
101. Kapikian AZ, Barile MF, Wyatt RG, et al. Mycoplasma contamination in cell culture of Crohn's disease material. Lancet 1979; 2(8140): 466-7.
102. Jiang X, Wang M, Wang K, Estes MK. Sequence and genomic organization of Norwalk virus. Virology 1993; 195(1): 51-61.
103. Greenberg HB, Gebhard RL, McClain CJ, Soltis RD, Kapikian AZ. Antibodies to viral gastroenteritis viruses in Crohn's disease. Gastroenterology 1979; 76(2): 349-50.
104. Gump D, Caul E, Eade O, et al. Lymphocytotoxic and microbial antibodies in Crohn's disease and matched controls. Antonie Van Leeuwenhoek 1981; 47(5): 455-64.
105. Graham J, Whorwell PJ, Machin D, Wright R. Lymphocyte transformation to specific antigens associated with Crohn's disease. Hepato-Gastroenterology 1981; 28(5): 258-60.
106. Khan RR, Lawson AD, Minnich LL, et al. Gastrointestinal norovirus infection associated with exacerbation of inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 2009; 48(3): 328-33.
107. Gebhard RL, Greenberg HB, Singh N, et al. Acute viral enteritis and exacerbations of inflammatory bowel disease. Gastroenterology 1982; 83(6): 1207-9.
108. Seth P. Adenoviruses: Basic Biology to Gene Therapy. Ginsberg HS (ed). 1999.
109. Biancone L, Pavia M, Del Vecchio Blanco G, et al. Hepatitis B and C virus infection in Crohn's disease. Inflammatory Bowel Diseases 2001; 7(4): 287-94.
110. Loras C, Saro C, Gonzalez-Huix F, et al. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. American Journal of Gastroenterology 2009; 104(1): 57-63.
111. Bargiggia S, Thorburn D, Anderloni A, et al. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study. Alimentary Pharmacology and Therapeutics 2005; 22(3): 209-15.
112. Hing MC, Goldschmidt C, Mathijs JM, Cunningham AL, Cooper DA. Chronic colitis associated with human immunodeficiency virus infection. The Medical Journal of Australia 1992; 156(10): 683-7.
113. Dourmashkin RR, Sanderson I, Walker-Smith JA, Dalgleish AG. Is Crohn's disease caused by a lymphotropic virus? Journal of Pediatric Gastroenterology and Nutrition 1986; 5(2): 334.
114. Schmidt I, Claesson CB, Westerholm B, Svarstad BL. Resident characteristics and organizational factors influencing the quality of drug use in Swedish nursing homes. Social Science & Medicine 1998; 47(7): 961-71.
115. Wang D, Urisman A, Liu YT, et al. Viral discovery and sequence recovery using DNA microarrays. PLoS Biology 2003; 1(2): E2.
116. Ambrose HE, Clewley JP. Virus discovery by sequence-independent genome amplification. Reviews in Medical Virology 2006; 16(6): 365-83.
117. Allander T, Emerson SU, Engle RE, Purcell RH, Bukh J. A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proceedings of the National Academy of Sciences of the United States of America 2001; 98(20): 11609-14.
118. Nakamura S, Yang CS, Sakon N, et al. Direct metagenomic detection of viral pathogens in nasal and fecal specimens using an unbiased high-throughput sequencing approach. PLoS One 2009; 4(1): e4219.
119. Philippson C Value of antibiotic combination therapy in chronic pyelonephritis--study on a large number of patients over a period of 15 years. Zeitschrift fur die gesamte innere medizin und ihre grenzgebiete 1977; 32(23): 661-5.
120. Oldstone MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 1988; 239(4839): 500-2.
121. Tonietti G, Oldstone MB, Dixon FJ. The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. The Journal of Experimental Medicine 1970; 132(1): 89-109.
122. Cadwell K, Patel KK, Maloney NS, et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010; 141(7): 1135-45.
123. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nature Genetics 2010; 42(12): 1118-25.
124. Leveque N, Brixi-Benmansour H, Reig T, et al. Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases. Journal of Medical Virology 2010; 82(10): 1694-700.
125. Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 1995; 108(5): 1396-404.
126. Touze I, Dubucquoi S, Cortot A, Van Kruiningen HJ, Colombel JF. IgM-specific measles-virus antibody in families with a high frequency of Crohn's disease. Lancet 1995; 346(8980): 967.
127. Iizuka M, Chiba M, Yukawa M, et al. Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease. Gut 2000; 46(2): 163-9.
128. Folwaczny C, Jager G, Schnettler D, Wiebecke B, Loeschke K. Search for mumps virus genome in intestinal biopsy specimens of patients with IBD. Gastroenterology 1999; 117(5): 1253-5.
129. Roche JK, Wold WS, Sanders PR, Mackey JK, Green M. Chronic inflammatory bowel disease: absence of adenovirus DNA as established by molecular hybridization. Gastroenterology 1981; 81(5): 853-8.
130. Reyes A, Haynes M, Hanson N, et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 2010; 466(7304): 334-8.